Duloxetine improves joint pain associated with aromatase inhibitor treatment for early-stage breast cancer |

                            
            Choose Speciality
              
Register

                         No new Notifications.

                          Profile

                          Change Password

                          Logout

Log In

Journal Updates

Duloxetine improves joint pain associated with aromatase inhibitor treatment for early-stage breast cancer

eMediNexus, 12 February 2018
570 Views
#Obstetrics and Gynecology #Oncology #Orthopedics #Radiology

According to a study reported online in the Journal of Clinical Oncology, treatment with duloxetine for aromatase inhibitor-associated musculoskeletal symptoms of joint pain, joint stiffness, functioning was superior to placebo among postmenopausal women with early-stage breast cancer.